Scarica l'app Stockscreener
1.00
8.70%
0.08
Dopo l'orario di chiusura:
.98
-0.02
-2.00%
Precedente Chiudi:
$0.92
Aprire:
$0.93
Volume 24 ore:
594.48K
Relative Volume:
1.25
Capitalizzazione di mercato:
$67.13M
Reddito:
-
Utile/perdita netta:
$-46.12M
Rapporto P/E:
-1.1571
EPS:
-0.8642
Flusso di cassa netto:
$-41.02M
1 W Prestazione:
+11.99%
1M Prestazione:
+11.27%
6M Prestazione:
-25.93%
1 anno Prestazione:
-38.65%
Intervallo 1D:
$0.914
$1.02
Intervallo di 1 settimana:
$0.82
$1.02
Portata 52W:
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
Confronta IFRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
1.00 | 62.39M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.50 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-29 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-02-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-10-28 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-04-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-05 | Downgrade | JP Morgan | Overweight → Underweight |
| 2019-06-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | Downgrade | SunTrust | Buy → Hold |
| 2019-01-29 | Iniziato | Robert W. Baird | Outperform |
| 2018-12-10 | Iniziato | Credit Suisse | Outperform |
| 2018-07-13 | Iniziato | BMO Capital Markets | Outperform |
| 2018-06-28 | Iniziato | Raymond James | Outperform |
| 2018-06-28 | Iniziato | SunTrust | Buy |
| 2018-02-08 | Iniziato | B. Riley FBR, Inc. | Buy |
Mostra tutto
Inflarx N V Borsa (IFRX) Ultime notizie
Leading vs lagging indicators on InflaRx N.V. performanceWeekly Trend Summary & Real-Time Stock Price Movement Reports - Newser
What momentum shifts mean for InflaRx N.V.2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
Top chart patterns to watch in InflaRx N.V.Weekly Trading Summary & Pattern Based Trade Signal System - Newser
How high can InflaRx N.V. stock goGDP Growth & Community Verified Trade Signals - Newser
Is InflaRx N.V. stock reversal real or fakePortfolio Risk Summary & Growth Focused Entry Point Reports - Newser
Tools to assess InflaRx N.V.’s risk profileEarnings Growth Summary & Expert Curated Trade Setup Alerts - Newser
Detecting support and resistance levels for InflaRx N.V.Entry Point & High Conviction Trade Alerts - Newser
Is InflaRx N.V. forming a bottoming base2025 Geopolitical Influence & Fast Entry Momentum Alerts - Newser
Can swing trading help recover from InflaRx N.V. lossesTreasury Yields & Daily Profit Focused Screening - Newser
Predicting InflaRx N.V. trend using moving averagesPrice Action & Risk Controlled Daily Trade Plans - Newser
InflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates - MSN
Will breakout in InflaRx N.V. lead to full recoveryJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - Newser
Will InflaRx N.V. see short term momentumPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
InflaRx N.V. stock momentum explainedBuy Signal & Safe Capital Growth Plans - Newser
Building trade automation scripts for InflaRx N.V.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-08-24 11:00:06 - Newser
What’s the fair value of InflaRx N.V. stockJuly 2025 Momentum & Risk Managed Investment Signals - theviewers.co.kr
Combining machine learning predictions for InflaRx N.V.Portfolio Value Report & Stepwise Swing Trade Plans - Newser
Why is InflaRx N.V. stock going upQuarterly Portfolio Report & AI Enhanced Trading Alerts - sundaytimes.kr
Sell Signal: What are InflaRx N.V.’s technical support levelsWatch List & AI Powered Trade Plan Recommendations - sundaytimes.kr
Inflarx N.V. shares fall 1.34% intraday after announcing participation in September investor conferences. - AInvest
InflaRx to participate in Cantor Global Healthcare Conference, H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
InflaRx Announces Participation in September Investor Conferences - GlobeNewswire
Biotech Innovator InflaRx to Showcase Anti-Inflammatory Pipeline at Major September Healthcare Conferences - Stock Titan
What to do if you’re stuck in InflaRx N.V.Portfolio Performance Summary & Weekly Watchlist of Top Performers - Newser
InflaRx N.V. Stock Approaches Key Moving AverageJuly 2025 Opening Moves & Verified Trade Idea Suggestions - 더경남뉴스
Real time social sentiment graph for InflaRx N.V.Analyst Upgrade & Growth Oriented Trading Recommendations - Newser
InflaRx N.V. stock chart pattern explained2025 Top Gainers & Stepwise Trade Signal Implementation - Newser
Regression analysis insights on InflaRx N.V. performanceJuly 2025 Volume & Free Community Supported Trade Ideas - Newser
What makes InflaRx N.V. stock price move sharply2025 Price Momentum & Risk Managed Trade Strategies - Newser
How moving averages guide InflaRx N.V. tradingOil Prices & Short-Term High Return Ideas - Newser
InflaRx receives Nasdaq notice for non-compliance with minimum bid price rule - MSN
Is InflaRx N.V. Stock a Good Fit for Conservative InvestorsQuarterly Profit Review & Long-Term Capital Growth Strategies - Newser
XTX Topco Ltd Buys New Shares in InflaRx N.V. (NASDAQ:IFRX) - Defense World
What MACD signals say about InflaRx N.V.Options Play & Long-Term Capital Growth Ideas - Newser
Is it time to cut losses on InflaRx N.V.Quarterly Profit Summary & Consistent Growth Equity Picks - Newser
Inflarx N V Azioni (IFRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):